As medical practitioners, it is crucial to stay informed about the latest developments in adult immunization. This article aims to provide an in-depth review of recent advances in adult vaccination, highlighting its importance in modern healthcare.
The Shingrix vaccine, a non-live, recombinant subunit vaccine, has replaced Zostavax as the preferred vaccine for herpes zoster (shingles). It offers over 90% efficacy, even among older adults, and is recommended for all adults aged 50 and above, including those previously vaccinated with Zostavax.
A new formulation of the Hepatitis B vaccine, Heplisav-B, has been introduced. It requires fewer doses than traditional vaccines, with a two-dose regimen over a month compared to the three-dose regimen over six months. This advancement increases the likelihood of complete immunization and is recommended for all adults aged 19 and above.
High-dose and adjuvanted influenza vaccines have been developed for older adults (65+ years). These formulations aim to enhance immune response, providing better protection against seasonal influenza. They are especially beneficial in reducing hospitalizations in the elderly population.
Revised guidelines for pneumococcal vaccination now recommend PCV13 for adults aged 65 and above, with certain risk factors. The PPSV23 vaccine is recommended for all adults in this age group, with an emphasis on a shared clinical decision-making process.
Staying updated with the latest advances in adult vaccination is critical in providing optimal patient care. The new formulations and revised guidelines provide enhanced protection, ease of administration, and improved patient compliance. As healthcare professionals, it is our responsibility to ensure these updates are integrated into our practice, contributing to the overall health of our adult population.
1.
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer
2.
Black Canadians Face Multiple Barriers to Blood Donation
3.
Stop Calling It Cancer; The Alcohol Paradox; Rural Patients Lose Ground in Screening
4.
Experts say oncology, primary care coordination necessary for best cancer patient outcomes
5.
Neural networks and label-free microscopy enable accurate detection of pancreatic tumors
1.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
2.
Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations
3.
Clinical Frameworks in Hematology for Better Care
4.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
5.
The Benefits of Understanding Haptoglobin High: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation